A new blood-based test could diagnose pancreatic cancer much earlier, improving outcomes for people with the disease.

Pancreatic cancer (PC) is the worst prognosis cancer globally, with just 13% of patients who are diagnosed with PC surviving for 5 years or more after initial diagnosis. Early detection of PC is the ...

Pancreatic cancer is fueled by connections to the nervous system. This is reported by scientists from the German Cancer ...

Due to a lack of noticeable symptoms in its early stages and the pancreas’ obscure location behind other organs in the ...

The discovery of a 'biomarker panel' could have a profound impact on the ability to identify patients at risk of developing ...

Pancreatic cancer immune map provides clues for precision treatment targeting Date: February 7, 2025 Source: University of Birmingham Summary: Pancreatic cancer patients may benefit from future ...

Phase I clinical trials are the first step in testing a new treatment or combination of treatments. These trials often ...

Researchers at Oregon Health and Science University (OHSU) have developed a blood test called PAC-MANN, to detect pancreatic ...

Pancreatic cancer is often discovered in advanced stages because it doesn’t usually cause symptoms until it has spread to other organs, limiting treatment options. The American Cancer Society ...

New blood test PAC-MANN detects pancreatic cancer early with 98% accuracy, offering hope for improved survival rates.

Pancreatic enzyme replacement therapy (Pert) provides the enzymes people affected by pancreatic cancer need to absorb ...